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Stellingen
1. Variant pathogenicity predictions can be biologically correct while still
false from a clinical perspective. (this thesis)
2. For some genes, evolutionary and structural properties seem to have no
bearing on the estimated pathogenicity of variants, hinting at control
by still unknown mechanisms. (this thesis)
3. In variant interpretation ”Too much emphasis on trying to prove pathogenic-
ity, runs the risk of the Texas Sharpshooter Fallacy” (– Gijs Santen1).
This risk can be minimized by using false discovery estimates from
healthy individuals. (this thesis)
4. Knowing the specific strengths and weaknesses of a method is ulti-
mately more important than its overall performance, however good,
for understanding that method’s true benefit. (this thesis)
5. In-vivo variant pathogenicity assays based on worm genetics could rep-
resent a great trade-off between ethics, cost and relevance for human
disease. (this thesis)
6. Semantic web technology is surprisingly under used, especially consid-
ering how data integration is always of prime concern in life science
projects. (this thesis)
7. Generating web databases from blueprints requires you to think about
the structure and meaning of data, which is its real advantage.
8. Journals should only accept papers with quality codebases that have
been tested and are comparable to lab experiments using controls.
9. With medicine that can repair the genome, we will no longer need to
be afraid of incidental findings.
10. ...however, with this new medicine, there will be a completely new
dilemma of what to do with ’likely pathogenic’ variants as identified
by genome diagnostics.
Propositions belonging to the doctoral thesis ’Translational software infras-
tructure for medical genetics’, by K. Joeri van der Velde, 2017
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http://biosb.nl/wp-content/uploads/2015/09/Day-3-Santen-Clinical-collaboration.pdf
